Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for Dyspepsia During Ramadan Fasting
NCT05287633Phase 2Completed
- Sponsor
- Université de Monastir
- Start
- Jan 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in dyspepsia comparing Esomeprazole with Placebo (2 arms). Primary endpoint: Overall symptom relief during the 4 weeks of treatment at 30 days. Started Jan 2020; status: completed.
02
Drugs
esomeprazole
03
Conditions
dyspepsia
Beyond the preview
Go deeper on NCT05287633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05287633.